Clinical Trial Services Market - Global Professional Analysis and Forecast to 2026
- REPORT SUMMARY
- TABLE OF CONTENTS
- INDUSTRY COVERAGE
The worldwide Clinical Trial Services market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.0% during the forecast period.
This report presents the market size and development trends by detailing the Clinical Trial Services market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Clinical Trial Services market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Clinical Trial Services industry and will help you to build a panoramic view of the industrial development.
Clinical Trial Services Market, By Type:
Phase 1
Phase 2
Phase 3
Clinical Trial Services Market, By Application:
Cancer
Cardiovascular
CNS
Infectious Diseases
Metabolic Diseases
Other Diseases
Some of the leading players are as follows:
Parexel
PRA
Labcorp
Wuxi Apptec
IQVIA
Medpace Holdings
Syneos Health
ICON
PPD
CRL
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Clinical Trial Services Market: Technology Type Analysis
-
4.1 Clinical Trial Services Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Clinical Trial Services Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Phase 1
4.3.2 Phase 2
4.3.3 Phase 3
5 Clinical Trial Services Market: Product Analysis
-
5.1 Clinical Trial Services Product Market Share Analysis, 2018 & 2026
-
5.2 Clinical Trial Services Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Clinical Trial Services Market: Application Analysis
-
6.1 Clinical Trial Services Application Market Share Analysis, 2018 & 2026
-
6.2 Clinical Trial Services Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Cancer
6.3.2 Cardiovascular
6.3.3 CNS
6.3.4 Infectious Diseases
6.3.5 Metabolic Diseases
6.3.6 Other Diseases
7 Clinical Trial Services Market: Regional Analysis
-
7.1 Clinical Trial Services Regional Market Share Analysis, 2018 & 2026
-
7.2 Clinical Trial Services Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Parexel
9.1.1 Parexel Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 PRA
9.2.1 PRA Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Labcorp
9.3.1 Labcorp Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Wuxi Apptec
9.4.1 Wuxi Apptec Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 IQVIA
9.5.1 IQVIA Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Medpace Holdings
9.6.1 Medpace Holdings Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Syneos Health
9.7.1 Syneos Health Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 ICON
9.8.1 ICON Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 PPD
9.9.1 PPD Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 CRL
9.10.1 CRL Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
The List of Tables and Figures (Totals 109 Figures and 150 Tables)
Figure Phase 1 Clinical Trial Services market, 2015 - 2026 (USD Million)
Figure Phase 2 Clinical Trial Services market, 2015 - 2026 (USD Million)
Figure Phase 3 Clinical Trial Services market, 2015 - 2026 (USD Million)
Figure Cancer market, 2015 - 2026 (USD Million)
Figure Cardiovascular market, 2015 - 2026 (USD Million)
Figure CNS market, 2015 - 2026 (USD Million)
Figure Infectious Diseases market, 2015 - 2026 (USD Million)
Figure Metabolic Diseases market, 2015 - 2026 (USD Million)
Figure Other Diseases market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Clinical Trial Services market, by country, 2015 - 2026 (USD Million)
-
Table North America Clinical Trial Services market, by type, 2015 - 2026 (USD Million)
-
Table North America Clinical Trial Services market, by product, 2015 - 2026 (USD Million)
-
Table North America Clinical Trial Services market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Clinical Trial Services market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Clinical Trial Services market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Clinical Trial Services market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Clinical Trial Services market, by type, 2015 - 2026 (USD Million)
-
Table Canada Clinical Trial Services market, by product, 2015 - 2026 (USD Million)
-
Table Canada Clinical Trial Services market, by application, 2015 - 2026 (USD Million)
-
Table Europe Clinical Trial Services market, by country, 2015 - 2026 (USD Million)
-
Table Europe Clinical Trial Services market, by type, 2015 - 2026 (USD Million)
-
Table Europe Clinical Trial Services market, by product, 2015 - 2026 (USD Million)
-
Table Europe Clinical Trial Services market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Clinical Trial Services market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Clinical Trial Services market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Clinical Trial Services market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Clinical Trial Services market, by type, 2015 - 2026 (USD Million)
-
Table Germany Clinical Trial Services market, by product, 2015 - 2026 (USD Million)
-
Table Germany Clinical Trial Services market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Clinical Trial Services market, by type, 2015 - 2026 (USD Million)
-
Table France Clinical Trial Services market, by product, 2015 - 2026 (USD Million)
-
Table France Clinical Trial Services market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Clinical Trial Services market, by type, 2015 - 2026 (USD Million)
-
Table Italy Clinical Trial Services market, by product, 2015 - 2026 (USD Million)
-
Table Italy Clinical Trial Services market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Clinical Trial Services market, by type, 2015 - 2026 (USD Million)
-
Table Spain Clinical Trial Services market, by product, 2015 - 2026 (USD Million)
-
Table Spain Clinical Trial Services market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Clinical Trial Services market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Clinical Trial Services market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Clinical Trial Services market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Clinical Trial Services market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Clinical Trial Services market, by type, 2015 - 2026 (USD Million)
-
Table China Clinical Trial Services market, by product, 2015 - 2026 (USD Million)
-
Table China Clinical Trial Services market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Clinical Trial Services market, by type, 2015 - 2026 (USD Million)
-
Table Japan Clinical Trial Services market, by product, 2015 - 2026 (USD Million)
-
Table Japan Clinical Trial Services market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Clinical Trial Services market, by type, 2015 - 2026 (USD Million)
-
Table India Clinical Trial Services market, by product, 2015 - 2026 (USD Million)
-
Table India Clinical Trial Services market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Clinical Trial Services market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Clinical Trial Services market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Clinical Trial Services market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Clinical Trial Services market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Clinical Trial Services market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Clinical Trial Services market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Clinical Trial Services market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Clinical Trial Services market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Clinical Trial Services market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Clinical Trial Services market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Clinical Trial Services market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Clinical Trial Services market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Clinical Trial Services market, by application, 2015 - 2026 (USD Million)
-
Table MEA Clinical Trial Services market, by country, 2015 - 2026 (USD Million)
-
Table MEA Clinical Trial Services market, by type, 2015 - 2026 (USD Million)
-
Table MEA Clinical Trial Services market, by product, 2015 - 2026 (USD Million)
-
Table MEA Clinical Trial Services market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Clinical Trial Services market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Clinical Trial Services market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Clinical Trial Services market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Clinical Trial Services market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Clinical Trial Services market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Clinical Trial Services market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Parexel Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table PRA Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Labcorp Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Wuxi Apptec Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table IQVIA Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Medpace Holdings Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Syneos Health Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table ICON Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table PPD Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table CRL Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis